Home | EndoTODAY | EndoATLAS

Beginner | ESA | Schedule | OPD

Seminars | Atlas | Recent | Links

EndoTODAY ³»½Ã°æ ±³½Ç


[EndoTODAY Update] - ðû


[2025-7-5] Oropharynx foreign body

»ý¼±°¡½Ã À̹°ÀÌ ±¸°­¿¡¼­ ¹ß°ßµÉ ¼ö ÀÖ½À´Ï´Ù. ÀüÅëÀûÀÎ Áø·á°ú ±¸ºÐ¿¡ µû¸£¸é ±¸°­Àº À̺ñÀÎÈİú ¿µ¿ª, ½Äµµ´Â ¼ÒÈ­±â³»°ú ¿µ¿ªÀÔ´Ï´Ù. ½ÇÁ¦·Î ±¸°­ foreign body´Â ´ëºÎºÐ À̺ñÀÎÈİú¿¡¼­ Á¦°ÅÇϰí ÀÖ½À´Ï´Ù. ¸ñ¿¡ À̹°ÀÌ ÀÖ´Ù°í ´À³¢´Â ºÐÀº À̺ñÀÎÈİú¸¦ ã±â ¶§¹®ÀÔ´Ï´Ù. ¸¹Àº º´¿ø¿¡¼­´Â ÀÀ±Þ½Ç·Î ³»¿øÇϽЏñÀ̹° ȯÀÚ´Â À̺ñÀÎÈİú·Î ¹èÁ¤µÇ±â ¶§¹®ÀÔ´Ï´Ù. ÇÏÁö¸¸ µå¹°°Ô À§Àå°ü ³»½Ã°æÀ¸·Î Á¦°ÅÇØ¾ß ÇÏ´Â °æ¿ìµµ ÀÖ½À´Ï´Ù. 2025³â 7¿ù 4ÀÏ SMC on-line ³»½Ã°æ ¼¼¹Ì³ª Áõ·Ê Áß vallecula¿¡¼­ ¹ß°ßµÈ fishboneÀÌ ÀÖ¾ú½À´Ï´Ù. ¹ê´óÀÌÁ£À» ¸Ô°í °É¸° °¡½Ã¿´½À´Ï´Ù. ù ³»½Ã°æ °Ë»ç¿¡¼­´Â ¹ß°ßÇÏÁö ¸øÇß´Ù°¡ Áõ»óÀÌ Áö¼ÓµÇ¾î Àç°ËÇÑ ³»½Ã°æ¿¡¼­ ¿ì¿¬È÷ ¹ß°ßÇÏ¿´´Ù°í ÇÕ´Ï´Ù. ÀúÈñ·Î¼­´Â ÂüÀ¸·Î ¾î·Á¿î »ç·Ê¶ó°í ÆÇ´ÜµË´Ï´Ù. ºñ½ÁÇÑ Áõ·Ê¸¦ ã¾Æº¸¾Ò½À´Ï´Ù.

Vallecula´Â tongue base¿Í epiglottis »çÀÌÀÔ´Ï´Ù.

Vallecula´Â À̺ñÀÎÈİú¿¡¼­ ÁøÂû ½Ã ÀÌ·¸°Ô º¸ÀÔ´Ï´Ù. µ¿¿µ»ó ¼³¸í

Vallecula´Â ³»½Ã°æÀ¸·Î °üÂû ½Ã ÀÌ·¸°Ô º¸ÀÔ´Ï´Ù. Upside downÀÌÁö¿ä. Çô°¡ 12½Ã ¹æÇâÀ̸é À§Àå°ü ³»½Ã°æÀÔ´Ï´Ù.

Ingested fish bone lodged in the vallecula. Cureus 2020

Usefulness of cap-fitted endoscopy in the collapsed pharyngeal space. A linear fish bone foreign body (FFB) is totally imbedded in the right vallecula on computed tomography (A). Serial photos to find, expose, and remove the imbedded FFB (B). The naked endoscopic tip cannot approach and visualized the collapsed space. The cap-fitted endoscopy is useful not only visualize the collapsed mucosa but also detect and expose the imbedded FFB by sweeping mucosa with the edge of the cap. Cap also makes the sufficient space to operate the forcep to remove the FFB in the collapsed space. ±èÈï¾÷ CE 2016

±èÈï¾÷ ±³¼ö´ÔÀÇ Á¾¼³¿¡´Â ÀÌ·¸°Ô ±â¼úµÇ¾î ÀÖ½À´Ï´Ù. Frequent lodging sites in the oropharynx are the tonsils, tongue base, valleculae, and pyriform recesses, the tonsils being the most common site.

Tongue-base fish bone. Çô°¡ 6½Ã ¹æÇâÀ̹ǷΠÀ̺ñÀÎÈİú¿¡¼­ °üÂûÇÑ °ÍÀÔ´Ï´Ù.


[2025-7-2] »ï¼º¼­¿ïº´¿ø º»°ü ³»½Ã°æ½Ç¿¡¼­ fellow 1³âÂ÷ ¼±»ý´ÔµéÀ» ¸ð½Ã°í Á¦1ȸ Mikoto colonoscopy simulator ÈÆ·ÃÀ» ÁøÇàÇÏ¿´½À´Ï´Ù. Tutor·Î Âü¿©ÇϽбèÀº¶õ ±³¼ö´Ô²² °¨»çµå¸³´Ï´Ù.

³»ºÎ¿¡¼­ÀÇ ¿òÁ÷ÀÓÀ» º¼ ¼ö ÀÖ½À´Ï´Ù.


[2025-7-1] Case Reviews in Gastroenterology (CRG) 3È£ ÃÊ°í°¡ ³ª¿Ô½À´Ï´Ù.

CRG 2±Ç 1È£ 2025³â º½ PDF 28.8M


[2025-6-28] ´ëÇѳ»°úÇÐȸ °­¿øÁöȸ ¿¬¼ö°­Á Áú¹®°ú ´äº¯

Q. Ç︮ÄÚ¹ÚÅÍ Ç×ü°Ë»ç¿¡¼­ °­¾ç¼ºÀ̸é Á¦±ÕÄ¡·á¸¦ Çϰí ÀÖ½À´Ï´Ù. È£±â°Ë»ç·Î È®ÀÎÇÏ¿© Á¦±Õ¼º°øÀ» È®ÀÎÇÑ È¯ÀÚ°¡ ¸¹¾Ò½À´Ï´Ù. °¡½ºÅä·ÎÆÄ³Ú °Ë»ç¸¦ Á» ´õ ±¤¹üÀ§ÇÏ°Ô ½ÃÇàµÇ¾î¾ß ÇÑ´Ù°í »ý°¢Çϴµ¥¿ä ±³¼ö´ÔÀÇ ÀǰßÀº?

A. Ç︮ÄÚ¹ÚÅ͸¦ Á¦°ÅÇÏ¿© À§¾ÏÀ» ¿¹¹æÇÏ´Â °ÍÀº ¸Å¿ì Áß¿äÇÑ ÀÏÀÔ´Ï´Ù. Serology, UBT, ³»½Ã°æÁ¶Á÷°Ë»ç µî ¾î¶² °Ë»çµµ ÁÁÀ¸´Ï Ç︮ÄÚ¹ÚÅ͸¦ È®ÀÎÇÏ¿© Ä¡·áÇÏ´Â °ÍÀº ±¹¹Î°Ç°­ÁõÁø¿¡ Å©°Ô µµ¿òÀÌ µÈ´Ù°í »ý°¢ÇÕ´Ï´Ù. Àú´Â 20¼¼¿¡ Ä¡·áÇÏÀÚ°í ºñ°ø½ÄÀûÀ¸·Î ÁÖÀåÇϰí ÀÖ½À´Ï´Ù. ´Ù¸¸ 30-40¼¼ À̻󿡼­´Â ³»½Ã°æ °Ë»ç ÈÄ Á¦±ÕÄ¡·á¸¦ ÇϽñ⠹ٶø´Ï´Ù. Serology °­¾ç¼ºÀº Ʋ¸²¾øÀÌ ¾ç¼ºÀÔ´Ï´Ù. Serology ¾àÀ½¼ºÀº °£È¤ false positiveÀÎ °æ¿ì°¡ ÀÖ½À´Ï´Ù.

Q. UBT À½¼º¿¡¼­ ¼öÄ¡´Â Àǹ̰¡ ÀÖ½À´Ï±î?

A. Å« Â÷À̰¡ ¾ø´Â °ÍÀ¸·Î ¾Ë°í ÀÖ½À´Ï´Ù. ¾ç¼º/À½¼º¸¸ º¸½Ã±â ¹Ù¶ø´Ï´Ù.

Q. ¾î¶² °æ¿ì ÀÚ°¡¸é¿ªÀ§¿°À» ÀǽÉÇմϱî?

A. °ú°Å¿¡´Â vitamin B12 ºÎÁ·¿¡ ÀÇÇÑ megaloblastic anemia¿¡¼­ Áø´ÜÇÏ¿´½À´Ï´Ù. ÃÖ±Ù¿¡´Â ³»½Ã°æ¿¡¼­ reverse atrophy°¡ º¸À̸é ÀǽÉÇÕ´Ï´Ù. ÀüÁ¤ºÎ´Â ºñ±³Àû ±ú²ýÇѵ¥ À§Ã¼ºÎ¿Í À§ÀúºÎÀÇ À§ÃàÀÌ ½ÉÇÒ ¶§ ÀǽÉÇÕ´Ï´Ù. ÀþÀº ³ªÀÌ¿¡¼­ À§³»½Ã°æ¿¡¼­ À§ÃàÀÌ ½ÉÇÒ ¶§µµ ÀǽÉÇÒ ¼ö ÀÖ½À´Ï´Ù. Gastropanel¿¡¼­ pepsinogen1/2 ºñÀ²ÀÌ ½ÉÇÏ°Ô ³·À» ¶§, ƯÈ÷ 1 ÀÌÇÏÀÏ ¶§ ÀǽÉÇÏ¼Å¾ß ÇÕ´Ï´Ù.


[2025-6-28. ´ëÇѳ»°úÇÐȸ °­¿øÁöȸ ¿¬¼ö°­ÁÂ] ÁÖÀº¿¬ ±³¼ö´ÔÀÇ ºÒ¸éÁõ °­ÀÇ


[2025-6-26] Mikoto colonoscopy model

Mikoto colonoscopy modelÀº ±âÁ¸ÀÇ ¸ðµ¨¿¡ ºñÇÏ¿© ÀÎü¿Í À¯»çÇÏ¿© fellow ±³À°¿¡ ¸Å¿ì À¯¿ëÇÒ °Í °°½À´Ï´Ù.

2024³â JDDW¿¡¼­ óÀ½ ½Ç¹°À» º¸¾Ò½À´Ï´Ù.

JDDW¿¡¼­´Â ÁÖ·Î Mikoto gastroscopy simulator¸¦ test ÇØ º¸¾Ò½À´Ï´Ù.

À§³»½Ã°æ simulator, ´ëÀå³»½Ã°æ simulator, ERCP simulator°¡ µû·Î °³¹ßµÇ¾î ÀÖ½À´Ï´Ù. À§³»½Ã°æ siulator´Â °ø±â¸¦ ³Ö°í »¬ ¼ö ÀÖ°í Á¡¼öµµ ³ª¿Í feedbackÀÌ µÈ´Ù´Â ÀåÁ¡ÀÌ ÀÖ½À´Ï´Ù. ºÎ½º¿¡¼­ ¸¸³­ ´ã´çÀÚ´Â Tsutomu kishigami

ȨÆäÀÌÁö link

īŻ·Î±× PDF

2025³â 6¿ù 26ÀÏ »ï¼º¼­¿ïº´¿ø ÀÓ»ó½Ã¹Ä·¹ÀÌ¼Ç ¼¾ÅÍ¿¡¼­ óÀ½À¸·Î Mikoto colonoscopy modelÀ» ½Ã¿¬ÇÏ¿´½À´Ï´Ù.

³»ºÎ´Â ÀÌ·¸°Ô »ý°å½À´Ï´Ù. ³­À̵µ·Î Á¶ÀýÇÒ ¼ö ÀÖ°í º¹ºÎ ¾Ð¹Úµµ ±¸ÇöÇÒ ¼ö ÀÖ½À´Ï´Ù.

±èż¼ ±³¼ö´Ô²²¼­ ½Ã¿¬ÇØ Áּ̽À´Ï´Ù.

³»ºÎ¿¡¼­ÀÇ ¿òÁ÷ÀÓÀ» º¼ ¼ö ÀÖ½À´Ï´Ù.

2025³â 7¿ù 2ÀÏ ¿ÀÈÄ 6½Ã »ï¼º¼­¿ïº´¿ø º»°ü ³»½Ã°æ½Ç¿¡¼­ fellow 1³âÂ÷ ¼±»ý´ÔµéÀ» ¸ð½Ã°í simulator ÈÆ·ÃÀ» ÁøÇàÇÒ °èȹÀÔ´Ï´Ù. (Tutor: ±èÀº¶õ ±³¼ö´Ô)


[2025-6-24] ¸ñÀÌ ±½Àº ¿ëÁ¾ ÀýÁ¦¼ú¿¡ detachable snare¸¦ Àâ¾ÆÁØ ÈÄ ±× À§¸¦ ÀýÁ¦ÇÏ´Â ¹æ¹ýÀ» »ç¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù.


[2025-6-21] ¹«½¼ Àå¸éÀϱî¿ä?

Á¤´äÀº ¿©±â¸¦ Ŭ¸¯ÇϽʽÿÀ.

Àú´Â »çÁ¤ÀÌ À־ Âü¼®ÇÏÁö ¸øÇß½À´Ï´Ù. ¿ì¸®³ª¶ó ³»½Ã°æ ÀÇ»çµéÀÇ Çб¸¿­ÀÌ ´ë´ÜÇÑ °ÍÀϱî¿ä? Ȥ½Ã ´Ù¸¥ ÀÌÀ¯´Â ¾ø´ÂÁö ±Ã±ÝÇÕ´Ï´Ù. À̹ø ¿©¸§ ¼¼¹Ì³ª´Â ²À Âü¼®ÇÏ·Á°í ÇÕ´Ï´Ù. On-lineÀ¸·Î.

... ±×·±µ¥ ¹«½¼ ÀÏÀÎÁö ¾Ë ¼ö ¾øÁö¸¸ feedbackÀÌ ÁÁÁö ¾Ê½À´Ï´Ù. Çб¸¿­ÀÌ ¾Æ´Ï¶ó´Âµ¥¿ä... ÁغñºÎÁ·À̾ú´ø °Í °°½À´Ï´Ù.

´ÙÀ½ ¼¼¹Ì³ª´Â on-line°ú off-line °øµ¿À¸·Î ÁøÇàµÈ´Ù°í ÇÏ´Ï ±×³ª¸¶ ´ÙÇàÀÔ´Ï´Ù.


[2025-6-20] ¹ÌºÐÈ­ Á¶Á÷Çü À§¾ÏÀ̰í Depressed lesion with central tumor islandÀÎÁö¶ó ¼ö¼úÀ» ±ÇÇß½À´Ï´Ù. ±×·±µ¥ ȯÀÚºÐÀº Ÿ ÀÇ·á±â°ü¿¡¼­ ESD¸¦ ¹ÞÀ¸¼Ì½À´Ï´Ù. °á±¹ ¼ö¼úÀ» ÇÏ°Ô µÇ¾ú½À´Ï´Ù. ÀÌÂ÷ ÀǰßÀ» ±¸ÇÑ´Ù´Â °ÍÀÌ ½ÇÁ¦ÀûÀ¸·Î ¾ó¸¶³ª µµ¿òÀÌ µÇ´ÂÁö Àú´Â Àß ¸ð¸£°Ú½À´Ï´Ù.


[2025-6-18] ±× µ¿¾È ÁÂÃø ÀϺ»Ã¥¸¸ ÀÖ¾î »ó¼¼ÇÑ ³»¿ëÀ» ÆÄ¾ÇÇϴµ¥ ¾î·Á¿òÀÌ ÀÖ¾ú´Âµ¥ ±Ý¹ø¿¡ ºÎ»ê´ë ±è±¤ÇÏ ±³¼ö´Ô²²¼­ ¹ø¿ªº»À» ³»¼Ì½À´Ï´Ù. Á¤¸» ÁÁÀº Ã¥ÀÔ´Ï´Ù. ¿ì¸®³ª¶ó ±³¼ö´ÔÀÌ ¾´ ÁÁÀº ESD Ã¥ÀÌ ¾ø´Ù´Â Á¡¿¡¼­ ¾Æ½¬¿òÀ» ±ÝÇÒ ¼ö ¾ø½À´Ï´Ù. Àúµµ ¾ðÁ¨°¡ ESD Ã¥À» ³»°í ½Í½À´Ï´Ù.


[2025-6-17] Position statement on ulcer in the evaluation of EGC

Àú´Â ´Ã °í¹ÎÇÕ´Ï´Ù. EGC III ó·³ ¸í¹éÇÑ cratered ulcer(¼­¾ç »ç¶÷µéÀÇ Ç¥ÇöÀÔ´Ï´Ù)´Â ulcer¶ó°í ºÎ¸¨´Ï´Ù. EGC IIcó·³ ¾èÀº ÇÔ¸ôºÎ´Â shallow ulcer ¶Ç´Â deep erosionÀ̶ó ºÎ¸¨´Ï´Ù. ³í¸®ÀûÀ̾î¾ß Çϰí politically safe ÇØ¾ß ÇÏ°í ±ÝÀüÀûÀ¸·Î ȯÀÚ°¡ ¼ÕÇØº¸¸é ¾È µÇ¹Ç·Î »óȲ¿¡ µû¶ó ¼±ÅÃÇÒ ¼ö ¹Û¿¡ ¾ø½À´Ï´Ù. Fold ¼Ò°ßÀÌ ¶Ñ·ÇÇϰí, cratered ulcer´Â ¾øÁö¸¸, ±×·¡µµ ulcerative lesionÀÌ Àִ ȯÀÚ¿¡ ÁØÇÑ Ä¡·á¸¦ ÇØ¾ß °Ú´Ù(= ¼ö¼úÀ» º¸³»¾ß°Ú´Ù)°í »ý°¢µÇ¸é ¶ä±Ý¾øÀÌ ulcer findingÀ̶ó´Â ¸»À» ¾¹´Ï´Ù. ´Ù¸¥ ½ÄÀ¸·Î ¸»Çϸé ESD¸¦ ÇØ¾ß ÇÒ °Í °°À¸¸é ulcer¶ó´Â Ç¥ÇöÀ» ÇÇÇϰí, ¼ö¼úÀ» ÇØ¾ß ÇÒ °Í °°À¸¸é ulcer ȤÀº ulcer findingÀ̶ó´Â Ç¥ÇöÀ» ¼±ÅÃÇÕ´Ï´Ù. ¿äÄÁµ¥ À°¾È¼Ò°ß¿¡ ±Ù°ÅÇÏ¿© Á߸³ÀûÀ¸·Î ¿ë¾î¸¦ ¼±ÅÃÇÏ¸é µÇ´Â ÀÏÀ» ÀÌ°Í Àú°Í ¸ðµÎ °í·ÁÇÏ¿© ¹®Á¦°¡ »ý±âÁö ¾Êµµ·Ï °ñ¶ó ¾²°í ÀÖ´Ù´Â ¸»¾¸ÀÔ´Ï´Ù. ¿ÖÀϱî¿ä? ClearÇÑ Á¤Àǰ¡ ¾ø±â ¶§¹®ÀÔ´Ï´Ù. ´©±¸³ª µ¿ÀÇÇϰí practically Àû¿ëÇÒ ¼ö ÀÖ´Â Á¤Àǰ¡ ¾øÀ¸¹Ç·Î Àü¹®°¡µé¸¶´Ù Àڱ⠹æ½ÄÀ¸·Î ¿ë¾î¸¦ ¼±ÅÃÇϰí ÀÖ´Â ½ÇÁ¤ÀÔ´Ï´Ù. ÀÇÇп¡´Â ÀÌ·± °ÍÀÌ ¾ÆÁÖ ¸¹½À´Ï´Ù. ScienceÀ̸鼭µµ artÀÔ´Ï´Ù. Science ¾Æ´Õ´Ï´Ù. Ã¥À¸·Î ¹è¿ï ¼ö ¾ø½À´Ï´Ù. ¼±»ý°ú ÇÔ²²ÇÏ´Â ±ä ½Ã°£ÀÌ ÇÊ¿äÇÕ´Ï´Ù. µµÁ¦±³À°°ú ³¡¾ø´Â Åä·Ð. ÀÇÇÐÀº ÀÌ·± °ÍÀ¸·Î À¯ÁöµÇ°í ¹ßÀüÇÕ´Ï´Ù.


[2025-6-16. µ¥Àϸ®¸Þµð] 80¼¼ ³ÑÀ¸¸é À§¾Ï¡¤´ëÀå¾Ï ³»½Ã°æ °ËÁø 'ºÒ¸íÈ®' - Çѱ¹º¸°ÇÀǷῬ±¸¿ø "ÀÏ·üÀûÀÎ °ËÁøº¸´Ù´Â °³º°Àû ÆÇ´Ü" ±Ç°í

±¹°¡¾Ï°ËÁø»ç¾÷¿¡¼­ ½ÃÇàÁßÀÎ À§¾Ï¡¤´ëÀå¾Ï ³»½Ã°æ °ËÁøÀÌ 80´ë À̻󿡼­´Â È¿°ú ¸íÈ®ÇÏÁö ¾Ê´Ù´Â ÆÇ´ÜÀÌ ³ª¿Ô´Ù. µû¶ó¼­ °í·ÉÃþÀº ÀÏ·üÀû °ËÁø ±Ç°íº¸´Ù´Â °³º°Àû ÆÇ´ÜÀ̳ª °øÀ¯ÀÇ»ç°áÁ¤ÀÌ ±ÇÀ嵯´Ù. 16ÀÏ Çѱ¹º¸°ÇÀǷῬ±¸¿ø ȯÀÚÁ᫐ ÀÇ·á±â¼ú ÃÖÀûÈ­ ¿¬±¸»ç¾÷´Ü(PACEN)Àº 80´ë À̻󿡼­´Â À§¾Ï?´ëÀå¾Ï °ËÁø È¿°ú°¡ ¸íÈ®ÇÏÁö ¾Ê´Ù´Â ÀÓ»óÀû °¡Ä¡Æò°¡ °á°ú¸¦ ¹ßÇ¥Çß´Ù. À̹ø °á°ú´Â ¡®È¿°ú¿Í ºñ¿ëÈ¿°ú¿¡ ±Ù°ÅÇÑ À§¾Ï ¹× ´ëÀå¾Ï °ËÁøÀÇ ÃÖÀû ¿¬·É Á¦¾È¡¯(¿¬±¸Ã¥ÀÓÀÚ ¿øÁÖ¼¼ºê¶õ½º±âµ¶º´¿ø ±èÇö¼ö ±³¼ö) ¿¬±¸°¡ ¹ÙÅÁÀÌ µÆ´Ù. ÀÓ»óÀû °¡Ä¡Æò°¡(appraisal)´Â ¿¬±¸ÀÇ ÁÖ¿ä °á°ú¸¦ ¿©·¯ ÀÌÇØ°ü°èÀÚ°¡ ´Ù°¢µµ·Î °ËÅäÇÏ°í ±¹¹Î¡¤È¯ÀÚÀÇ °üÁ¡¿¡¼­ Á¤¸®¡¤¹èÆ÷ÇØ ÇÕ¸®ÀûÀÎ ÀÇ·á¼­ºñ½º ¼±ÅÃÀ» Áö¿øÇϰíÀÚ ¼öÇàµÈ´Ù.

ÇöÀç ±¹°¡¾Ï°ËÁø»ç¾÷¿¡¼­´Â ´ëÀå¾Ï °ËÁøÀÇ °æ¿ì 50¼¼ ÀÌ»óÀº 1~2³â¸¶´Ù ºÐº¯ÀáÇ÷°Ë»ç¸¦ ½Ç½ÃÇÑ´Ù. ºÐº°ÀáÇ÷°Ë»ç°¡ ¾ç¼ºÀÏ ¶§ ´ëÀå³»½Ã°æÀ» ±ÇÀåÇϰí ÀÖ´Ù. À§¾Ï °ËÁøÀº 40¼¼ ÀÌ»ó ¼ºÀÎÀ» ´ë»óÀ¸·Î 2³â¸¶´Ù À§³»½Ã°æ ¶Ç´Â »óºÎÀ§Àå°üÁ¶¿µ°Ë»ç¸¦ ½ÃÇàÇϰí, °ËÁøÀÇ »óÇÑ ¿¬·É¿¡ ´ëÇÑ Á¦ÇÑÀº ¾ø´Ù. ÇÏÁö¸¸ ±¹³» ÇÐȸ °ËÁø ±Ç°í¾È¿¡ µû¸£¸é ´ëÀå¾ÏÀÇ °æ¿ì 81¼¼ ÀÌ»óÀº °ËÁø È¿°ú¸¦ µÞ¹ÞħÇÒ ±Ù°Å°¡ ºÎÁ·ÇÏ´Ù°í ÁöÀûÇϰí ÀÖ´Ù. À§¾Ï ¶ÇÇÑ 85¼¼ ÀÌ»óÀº À§¾Ï ¹ß»ý·üÀÌ ³·°í, °ËÁøÀ¸·Î ÀÎÇØ »ç¸ÁÇÒ ¼ö ÀÖ¾î À§¾Ï °ËÁøÀ» ±Ç°íÇÏÁö ¾Ê´Â´Ù.

ÀÌ¿¡ ¡®È¿°ú¿Í ºñ¿ëÈ¿°ú¿¡ ±Ù°ÅÇÑ À§¾Ï ¹× ´ëÀå¾Ï °ËÁø ÃÖÀû ¿¬·É Á¦¾È¡¯ ¿¬±¸¿¡¼­ PACEN Áö¿øÀ» ¹Þ¾Æ °í·ÉÀÚ¿¡¼­ À§¾Ï, ´ëÀå¾Ï ³»½Ã°æ °ËÁøÀÇ ÀûÁ¤¼ºÀ» Æò°¡Çß´Ù. ´ëÀå¾Ï °ËÁø(´ëÀå³»½Ã°æ)Àº 2004³âºÎÅÍ 2020³â±îÁö °Ç°­º¸Çè û±¸ÀÚ·á(75¼¼ ÀÌ»ó ¼ö°ËÀÚ ¾à 1¸¸9000¸í, ºñ¼ö°ËÀÚ ¾à 1¸¸9000¸í)¸¦ ºÐ¼®Çß´Ù. ±× °á°ú 79¼¼±îÁö´Â ´ëÀå¾Ï ¹ß»ý·üÀÌ 30% °¨¼ÒÇØ ´ëÀå¾Ï ¹ß»ý ¾ïÁ¦ È¿°ú°¡ °üÂûµÆÁö¸¸ 80¼¼ À̻󿡼­´Â È¿°ú°¡ ¶Ñ·ÇÇÏÁö ¾Ê¾Ò´Ù. À§¾Ï °ËÁø(À§³»½Ã°æ)Àº 2009³âºÎÅÍ 2020³â±îÁö ±¹°¡¾Ï°ËÁø ÀÚ·á(75¼¼ ÀÌ»ó ¼ö°ËÀÚ ¾à 8¸¸6000¸í, ºñ¼ö°ËÀÚ ¾à 8¸¸6000¸í)¸¦ ºÐ¼®Çß´Ù. ÇØ´ç ºÐ¼®¿¡¼­ 79¼¼±îÁö´Â À§¾Ï »ç¸Á·üÀÌ 43% °¨¼ÒÇѵ¥ ºñÇØ, 80¼¼ À̻󿡼­´Â À§¾Ï »ç¸Á ¾ïÁ¦ È¿°ú°¡ »ó´ëÀûÀ¸·Î ³·¾ÆÁ³´Ù. »óÇÑ ¿¬·É È®ÀÎÀ» À§ÇØ 1¼¼ ´ÜÀ§·Î ºÐ¼®ÇÏ¿´À»¶§, 80¼¼±îÁö´Â À§¾Ï »ç¸Á ¾ïÁ¦ È¿°ú°¡ °üÂûµÆÁö¸¸ 81¼¼ À̻󿡼­´Â È¿°ú°¡ ¶Ñ·ÇÇÏÁö ¾Ê¾Ò´Ù.

ÀÓ»óÀû °¡Ä¡Æò°¡ ȸÀÇ¿¡ Âü¼®ÇÑ Àü¹®°¡µéÀº 80´ë À̻󿡼­´Â ÀÏ·üÀûÀ¸·Î °ËÁøÀ» ±Ç°íÇϱ⺸´Ù °³ÀÎÀÇ °Ç°­ »óÅÂ, ±â´ë¼ö¸í, ¾Ï À§Çèµµ µîÀ» °í·ÁÇØ °ËÁø ¿©ºÎ¸¦ °³º°ÀûÀ¸·Î ÆÇ´ÜÇØ¾ß ÇÑ´Ù´Â ÀǰßÀ» Á¦½ÃÇß´Ù. ¶ÇÇÑ, ³»½Ã°æ °ËÁø ¿©ºÎ¸¦ ÆÇ´ÜÇÏ´Â °úÁ¤¿¡¼­ ȯÀÚ¿Í ÀÇ·áÁøÀÌ ÃæºÐÈ÷ »óÀÇÇÏ´Â °øÀ¯ ÀÇ»ç°áÁ¤(shared-decision making)ÀÌ Áß¿äÇÏ´Ù´Â °ßÇØµµ ÇÔ²² ¾ð±ÞÇß´Ù.


[2025-6-15] º´¸®¿¡¼­ »ç¿ëÇÏ´Â ¿©·¯ metaphor Áß ÀϺÎÀÔ´Ï´Ù.


[2025-6-13] ÁøÁ¤(¼ö¸é) ³»½Ã°æ ÈÄ ±³Åë»ç°í´Â °è¼ÓµÇ°í ÀÖ½À´Ï´Ù. ¿Ö ÇÏÁö ¸»¶ó´Â ÀÏÀ» °è¼Ó ÇϽôÂÁö... ¾Ë ¼ö ¾ø½À´Ï´Ù.

Áö³­ 3¿ù 31ÀÏ ¿ÀÀü 10½Ã²², °æ±â ¼º³²½Ã ºÐ´ç±¸ Á¤ÀÚµ¿ÀÇ ÇÑ µµ·Î¿¡¼­ ÀÌ °°Àº ³»¿ëÀÇ 112 ½Å°í°¡ ÀÕµû¶ó Á¢¼öµÆ´Ù. Æíµµ 6Â÷·Î Áß 5Â÷·Î¿¡ ¾Õ ¹üÆÛ°¡ ÆÄ¼ÕµÈ ä ¿À·£ ½Ã°£ Á¤Â÷ÇÑ Àç±Ô¾î Â÷·®ÀÌ ±³Åë üÁõÀ» À¯¹ßÇϰí ÀÖ¾ú±â ¶§¹®ÀÌ´Ù. ÇöÀåÀ» ¸ñ°ÝÇÑ ÇÑ ¿îÀüÀÚ´Â ÀÌ»óÇÔÀ» ´À³¢°í Á÷Á¢ Àç±Ô¾î Â÷·® ¿îÀü¼® ¹®À» ¿­¾î ¸»À» °É¾ú°í, ÀÌ¿¡ 60´ë ¿îÀüÀÚ A¾¾´Â ¸¶Ä¡ Àá¿¡¼­ ±ü µí ³î¶õ ¸ð½ÀÀ¸·Î Á¤½ÅÀ» Â÷¸®°í Â÷¸¦ ´Ù½Ã ¸ô±â ½ÃÀÛÇß´Ù. ¸¶Ä§ ÇöÀå¿¡ Ã⵿ÇÑ °æÂûÀº ÇØ´ç Â÷·®¿¡ Á¤Â÷¸¦ ¸í·ÉÇßÁö¸¸, A¾¾´Â À̸¦ ¹«½ÃÇÏ°í ¾à 1km¸¦ ´õ ¿îÀüÇÏ´Ù ½ÅÈ£´ë±â ÁßÀÌ´ø Â÷·®À» µéÀ̹޴ »ç°í¸¦ ³Â´Ù. ´ç½Ã À½ÁÖ ¹ÝÀÀÀº ¾ø¾úÁö¸¸, ¸¶¾à·ù Á¤¹Ð°Ë»ç °á°ú ÇâÁ¤½Å¼º ÀǾàǰÀÎ ¹Ì´ÙÁ¹¶÷ÀÌ °ËÃâµÆ´Ù. Á¶»ç °á°ú A¾¾´Â Á÷Àü º´¿ø¿¡¼­ °Ç°­°ËÁøÀ» ¹ÞÀ¸¸ç ¼ö¸é¸¶Ã븦 Çß°í, ¸¶Ãë¿¡¼­ ¿ÏÀüÈ÷ ȸº¹µÇÁö ¾ÊÀº »óÅ¿¡¼­ Â÷·®À» ¿îÀüÇÑ °ÍÀ¸·Î µå·¯³µ´Ù. º´¿ø ÁöÇÏ ÁÖÂ÷ÀåÀ» ºüÁ®³ª¿À´ø Áß¿¡µµ ¿¬¼®À» µéÀ̹޴ »ç°í¸¦ ³»´Â µî, ÃÑ 3km ±¸°£À» ºÒ¾ÈÁ¤ÇÑ »óÅ·ΠÁÖÇàÇÑ °ÍÀ¸·Î ÆÄ¾ÇµÆ´Ù. ºÐ´ç°æÂû¼­´Â A¾¾°¡ ¾à¹° ¿µÇâÀ¸·Î Á¤»óÀûÀÎ ¿îÀüÀÌ ¾î·Á¿î »óÅ¿¡¼­ ¿îÀüÇÏ´Ù »ç°í¸¦ ³½ °ÍÀ¸·Î º¸°í Çü»ç ÀÔ°ÇÇß´Ù. µµ·Î±³Åë¹ý À§¹Ý ¹× ƯÁ¤¹üÁË °¡Áßó¹ú µî¿¡ °üÇÑ ¹ý·ü À§¹Ý(À§Çè¿îÀüÄ¡»ó)ÀÌ´Ù. °æÂû °ü°èÀÚ´Â ¡°¾à¹°·Î ÀÎÇØ ¿îÀü ´É·ÂÀÌ ÇöÀúÈ÷ ¶³¾îÁö´Â »óÅ¿¡¼­ ¿îÀüÇÏ´Â °ÍÀº ¸í¹éÇÑ ºÒ¹ý¡±À̶ó¸ç ¡°¼ö¸é¸¶Ãë ÈÄ¿¡´Â ¹Ýµå½Ã ȸº¹ ½Ã°£À» ÃæºÐÈ÷ °®°í ¿îÀüÇØ¾ß ÇÑ´Ù¡±°í °­Á¶Çß´Ù.


[2025-6-13] ÃʽÉÀÚ¸¦ À§ÇÑ Á¶±âÀ§¾Ï ³»½Ã°æÄ¡·á Áõ·Ê ÅäÀÇ - clinical decision makingÀ» Áß½ÉÀ¸·Î

PDF 4.2M


[2025-6-13] ´ëÀå¾Ï Á¡¸·ÇÏħÀ±. Submucosal invasion in colon cancer

³»½Ã°æÀ¸·Î ÀýÁ¦ÇÑ ´ëÀå¾ÏÀÇ Ä§À±±íÀÌ Æò°¡´Â Á¦¹ý ±î´Ù·Ó½À´Ï´Ù. ´ëÀå¾Ï º´¸®º¸°í¼­ ±âÀç¹æ¾È Ç¥ÁØÈ­ 2ÆÇ(PDF, 2019)¿¡¼­ Á¦½ÃµÈ ±âÁØ¿¡ µû¸£¸é pedunculated tumor¿Í sessile tumor¿¡¼­ ¼­·Î ´Ù¸¥ ±âÁØÀÌ Á¦½ÃµÇ¾î ÀÖ½À´Ï´Ù. À¯°æ¼º Æú¸³Àº Haggitt levelÀÇ neck (level 2)ÀÌ Ä§À±À» ÃøÁ¤ÇÏ´Â ±âÁØÀÔ´Ï´Ù.

´ëÀå¾Ï º´¸®º¸°í¼­ ±âÀç¹æ¾È Ç¥ÁØÈ­ 2ÆÇ(PDF, 2019)¿¡¼­ Á¦½ÃµÈ ±âÁØ


[2025-6-9] Obstruction Áõ»óÀ¸·Î »ý¾Ö ù ³»½Ã°æ¿¡¼­ ¹ß°ßµÈ ÁøÇ༺ À§¾Ï

2025-6-9


[2025-6-6] Á÷Àå°æ µÎ Áõ·Ê. Right-sided colon cancer with hepatic metastasis. Neuroendocrine tumor with lymph node metastasis

2025-6-6


[2025-6-4] Review of two EGCs

2025-6-4


[2025-6-2] Ulcer, ulceration, ulcer finging

2025-6-2

¸¶Áö¸·Àå µÎ¹øÂ° ÁÙÀ» "¾èÀº ulcer´Â Á¡¸·¾ÏÀÏ °¡´É¼ºÀÌ ÀÖÀ¸¹Ç·Î ESD¸¦ ½ÃµµÇÑ´Ù."·Î Á¤¸®ÇÕ´Ï´Ù. È¥¼±À» µå·Á¼­ Á˼ÛÇÕ´Ï´Ù.

Ulcer findingÀº ¿¬±¸¸¶´Ù ±× ºóµµ°¡ ´Ù¸¨´Ï´Ù. ÆÇÁ¤ ±âÁØÀÌ ´Ù¸£´Ù´Â À̾߱âÀÔ´Ï´Ù.

¾È¼ö¹Î ±³¼ö´Ô °­ÀÇ


[2025-5-30. ¾Öµ¶ÀÚ Áú¹®] Oxyntic gland adenoma

Oxyntic gland neoplasm¿¡ ´ëÇÑ Áú¹®ÀÔ´Ï´Ù. ±Ã±ÝÇÑ °ÍÀº °øºÎÁß¿¡ fundic gland polypÀÌ °á±¹ oxyntic mucosa¿¡¼­ ¹ß»ýÇÏ´Â °ÍÀε¥ fundic gland dysplasiaµµ oxyntic gland neoplasmÀ¸·Î º¼ ¼ö´Â ¾ø´Â °ÍÀÎÁö ÀÌÇØ°¡ Àß °¡Áö°¡ ¾Ê½À´Ï´Ù. Oxyntic gland neoplasmÀ̶ó Çϸé Oxyntic gland adenoma ¿Í ADC of fundic gland type¸¸ ³íÇϰí fundic gland dysplasia °°Àº °æ¿ì ã¾Æº¸¸é FAP ȯÀÚ¿¡¼­ ÁÖÀÇÇØ¾ßÇÒ »çÇ×À̶ó°í¸¸ ³íÇϰí À־ °³³ä ÀÚü°¡ Çò°¥¸³´Ï´Ù. ¿£µµÅõµ¥ÀÌ¿Í À§Áúȯ ³»½Ã°æ ¾ÆÆ²¶ó½º¿¡¼­µµ Oxyntic gland adenoma »ç·Ê·Î fundic gland dysplasia¸¦ ¼Ò°³ÇØÁ̴ּµ¥, Ȥ½Ã FAP ȯÀÚ°¡ ¾Æ´Ñ °æ¿ì fundic gland dysplasia¶ó°í º´¸® ÆÇµ¶ÀÌ ³ª¿Â´Ù¸é oxyntic gland neoplasmÀ¸·Î º¼ ¼ö ÀÖ´Â °ÍÀϱî¿ä? ±âÃÊÀûÀÎ Áú¹® Á˼ÛÇÕ´Ï´Ù.

[2025-5-30. ÀÌÁØÇà ´äº¯]

ÁÁÀº Áú¹® °¨»çÇÕ´Ï´Ù. Àúµµ ¾ÆÁ÷ Á¤È®È÷ °³³ä°ú ¿ë¾î¸¦ Á¤¸®ÇÏÁö ¸øÇß½À´Ï´Ù. ÀÏ´Ü ¸®ºäÀÇ ±×¸²°ú WHO blue book (5ÆÇ)ÀÇ tumors of the stomachÀÇ ¸ñÂ÷¸¦ Àß º¸½Ã±â ¹Ù¶ø´Ï´Ù.

Histopathology 2021

WHO blue book 5ÆÇ

Gastric gland´Â pyloric gland¿Í fundic gland (= oxyntic gland)·Î ³ª´©¾îÁý´Ï´Ù. ÀÌ µÎ Á¾·ù gland ¸ðµÎ pit (= foveola)¿Í proper gland·Î ±¸¼ºµË´Ï´Ù. NeoplasmÀº pit (= foveolar epithelium)¿Í proper gland ¸ðµÎ¿¡¼­ ¹ß»ýÇÒ ¼ö ÀÖ½À´Ï´Ù. Àú´Â ¾Æ·¡¿Í °°Àº °³³äÀ» °¡Áö°í ÀÖ½À´Ï´Ù.

PitProper gland
À§Ä¡AntrumBody/FundusAntrumBody/Fundus
Non-dysplastic polypHyperplastic polyp?Fundic gland polyp
DysplasiaIntestinal type adenoma (=tubular adenoma) and foveolar type adenomaPyloric gland adenomaOxyntic gland adenoma
CancerGastric adenocarcinomaGastric type adenocarcinomaAdenocarcinoma of fundic gland type

Pit (= foveolar epithelium)¿¡¼­ ¹ß»ýÇÏ´Â °ÍµéÀº antrumÀ̳ª body/fundusÀÇ Â÷À̰¡ ¾øÀ¸¹Ç·Î ½±½À´Ï´Ù. WHO blue book 5ÆÇ 92ÂÊ gastric adenocarcinoma of fundic gland type ¼³¸íÀ» º¸¸é "This type is assumed to develop from oxyntic gland adenoma."¶ó°í ºÐ¸íÈ÷ ¾º¿© ÀÖ½À´Ï´Ù. Á¦°¡ º¸±â¿¡´Â oxyntic gland¿Í fundic gland°¡ °ÅÀÇ °°Àº ÀǹÌÀÌ¸ç ´Ü¼øÈ÷ óÀ½ À̸§ÁöÀº °ü·Ê¿¡ µû¶ó (1) non-dysplastic º´¼Ò´Â fundic gland polypÀ¸·Î, (2) non-cancer dysplasia º´¼Ò´Â oxyntic gland adenoma·Î, (3) cancer´Â gastric adenocarcinoma of fundic gland type·Î ºÎ¸£°í ÀÖÀ» »ÓÀÎ °Í °°½À´Ï´Ù. µû¶ó¼­ Á¦ ¸Ú´ë·Î »õ·Î À̸§À» Áþ´Â´Ù¸é fundic gland proper¿¡¼­ ¹ß»ýÇÏ´Â ¿©·¯ ÁúȯÀ» (1) fundic gland polyp = oxyntic gland polyp, (2) fundic gland adenoma = oxyntic gland adenoma, (3) adenocarcinoma of fundic gland type = fundic gland adenocarcinoma = oxyntic gland adenocarcinoma·Î ¸í¸íÇÏ°í ½Í½À´Ï´Ù. ºñ½ÁÇÑ ¹æ½ÄÀ¸·Î pyloric gland proper¿¡¼­ ¹ß»ýÇÏ´Â °ÍÀº (1) pyloric gland adenoma = gastric gland adenoma, (2) gastric type adenocarcinoma = pyloric adenocarcinoma·Î ¸í¸íÇÏ°í ½Í½À´Ï´Ù.

¾Æ·¡´Â ÀúÀÇ ÁÖÀåÀÔ´Ï´Ù. ÀÌ·¸°Ô °£´ÜÈ÷ Á¤¸®ÇÏ¸é ¾ó¸¶³ª ÁÁÀ»±î¿ä?

Proper gland¿¡¼­ ¹ß»ýÇÏ´Â º´¼Ò¿¡ ´ëÇÑ ¸í¸í¹ý ÅëÀÏ¾È (ÀÌÁØÇà Á¦¾È. 2025-5-30)
À§Ä¡AntrumBody/Fundus
Non-dysplastic polyp?Fundic gland polyp
DysplasiaPyloric gland adenomaFundic gland adenoma
CancerPyloric gland adenocarcinomaFundic gland adenocarcinoma

¾ÆÁ÷ fundic gland polyp¿¡ ´ëÀÀÇÏ¿© antrumÀÇ pyloric gland proper¿¡¼­ ¹ß»ýÇÏ´Â polyp¿¡ ´ëÇÑ Æ¯º°ÇÑ À̸§Àº ¾ø´Â °Í °°½À´Ï´Ù. ±×·¡¼­ ?Ç¥ ÀÔ´Ï´Ù.

Dysplasia¿Í adenoma¿¡ ´ëÇÑ °³³äÀº ¶Ç ´Ù¸¥ ¹®Á¦Àε¥, Àú´Â °£´ÜÈ÷ dysplasia°¡ ÀÖÀ¸¸é adenoma·Î ºÎ¸¥´Ù°í »ý°¢ÇÕ´Ï´Ù. ÀÌ¿¡ ´ëÇØ¼­´Â EndoTODAY À§¼±Á¾¿¡¼­ ÀÚ¼¼È÷ ±â¼úÇØ µÎ¾ú½À´Ï´Ù.

º¯¸í ÇÑ ¸¶µð µ¡ºÙÀÔ´Ï´Ù. Àúµµ ¾ÆÁ÷ Á¤È®È÷ °³³ä°ú ¿ë¾î¸¦ Á¤¸®ÇÏÁö ¸øÇÑ ÀÌÀ¯´Â °á±¹ º´¸®ÇÐÀÚµéÀÌ °¢ÀÚ Àû´çÇÏ´Ù°í »ý°¢Çϴ¿ë¾î¸¦ ¸¸µé¾î »ç¿ëÇÏ¿´´Âµ¥ À̸¦ ¸ð¾Æ Á¤¸®ÇÏ´Â ÀÛ¾÷À» ÇÏÁö ¸øÇÑ Å¿ÀÌ Å« °Í °°½À´Ï´Ù. ƯÈ÷ stomach ºÎºÐÀº ÀϺ» º´¸®ÀÇ»ç¿Í ¼­¾ç º´¸®ÀÇ»çµéÀÌ ¿µ ÀǰßÀ» ¸ÂÃßÁö ¸øÇϰí À־ ´õ¿í Çò°¥¸³´Ï´Ù. ±×·¯³ª ÃÖ±Ù WHO blue bookÀ» º¸¸é °ú°Åº¸´Ù´Â ¸¹ÀÌ Á¤¸®°¡ µÇ¾î ÀÖ½À´Ï´Ù. ¾ðÁ¨°¡´Â ÅëÀϾÈÀÌ ³ª¿À°ÚÁö¿ä. ±â´ëÇØ º¾´Ï´Ù.


[2025-5-30] Àú´Â Ç︮ÄÚ¹ÚÅÍ Á¦±ÕÄ¡·á¿¡ À־ °æÇèÀû Ä¡·á¸¦ »ç¿ëÇϹǷΠ³»¼º °Ë»ç¸¦ ¿¬±¸ ¸ñÀû À̿ܿ¡´Â ó¹æÇØ º» ÀûÀÌ ¾ø½À´Ï´Ù. ´Ù¸¸ °¡²û Ÿ ÀÇ·á±â°ü¿¡¼­ À¯ÀüÀÚ °Ë»ç ÈÄ ÀÇ·ÚµÈ È¯ÀÚ°¡ À־ ´Ã °í¹ÎÇϰí ÀÖ½À´Ï´Ù. °¡Àå ÃÖ½ÅÀÇ °¡À̵å¶óÀÎÀ» µû¸¦ ¼ö ¹Û¿¡ ¾ø´Ù°í »ý°¢ÇÕ´Ï´Ù. Áï PAM 1ÁÖ Ã³¹æÀ» ¼±ÅÃÇϰí ÀÖ½À´Ï´Ù.

2020³â °¡À̵å¶óÀÎ ¿ä¾àÇ¥

[2025-5-30] KSGE ³»½Ã°æÇÐȸ¿¡¼­ ³»½Ã°æ ÇÚÁî¿Â Æ®·¹ÀÌ´×À» °è¼ÓÇϰí ÀÖ´Â ¸ð¾çÀÔ´Ï´Ù. ´ÙÇàÀÔ´Ï´Ù. ±×·±µ¥ ´ë»óÀÌ ³»°ú Àü°øÀÇ 3³âÂ÷Àä... ¾à°£ °ÆÁ¤ÀÌ µÇ±â´Â ÇÕ´Ï´Ù.


[2025-5-29] ÀÜÀ§ µé¹® º¸¸¸ 4Çü ÁøÇ༺ À§¾Ï

2025-5-29


[2025-5-28] Push type PEG hands-on trainingÀ» ¼Ò°³ÇÕ´Ï´Ù.

Setup

óÀ½¿¡´Â EndoGEL ESD Á¾ÀÌ ¹Ú½º¿¡ ¿Ü°ú¿¡¼­ »ç¿ëÇÏ´Â º¹º® ¸ðµ¨À» ¶Ñ²±Ã³·³ ¸¸µé¾î ¿¬½ÀÇß½À´Ï´Ù.

Á¾ÀÌ ¹Ú½º ¸ðµ¨À» ¹ßÀü½ÃÄÑ ÇÃ¶ó½ºÆ½ ¿¬½ÀƲÀ» °³¹ßÇÏ¿´½À´Ï´Ù.

Koken simulator¿¡ ¿¬°áÇÏ¿© ¿¬½ÀÇϰí ÀÖ½À´Ï´Ù.

±èż¼ ±³¼ö´ÔÀÇ demonstration Àå¸éÀÔ´Ï´Ù. (2025-5-28)


[2025-5-28. ¾Öµ¶ÀÚ ÆíÁö]

±³¼ö´Ô, ¾È³çÇϼ¼¿ä. ³»½Ã°æÇϸ鼭 Èñ±ÍÇÑ °æ¿ì À־ ¿¬¶ôµå·Áº¾´Ï´Ù. ¾ð¶æ º¸¸é »ì±¸¾¾, °í±â À̹° Á¦°Å ÈÄ °°Áö¸¸, Histoacryl injection Çß´ø ȯÀÚÀε¥, ³»½Ã°æ Çϸ鼭 histoacrylÀÌ ¶³¾îÁ®³ª¿Í¼­ ³×Æ®·Î °È¾î¿Ã·È½À´Ï´Ù.


[2025-5-27] Satoshi Ono¶ó´Â ÀϺ»ÀÎÀÌ ¾´ ¼ÒÈ­±â³»½Ã°æ Tips 2¶ó´Â Ã¥À» ±¸ÀÔÇÏ¿© »ìÆìº¸´ø Áß blind area¿¡ ´ëÇÑ Èï¹Ì·Î¿î ±â¼úÀÌ ÀÖ¾ú½À´Ï´Ù. ±×·¸½À´Ï´Ù. Èĺ®ÀÇ ÀÛÀº º´¼Ò´Â ÈçÈ÷ ³õĨ´Ï´Ù. À§°¢ º´¼Òµµ ³õÄ¡±â ½±½À´Ï´Ù. ÇÕÇϸé À§°¢ Èĺ®À̳ª À§Ã¼ÇϺΠÈĺ® º´¼Ò´Â ÂüÀ¸·Î ÈçÈ÷ miss ÇÕ´Ï´Ù.

*°ü·Ã Áõ·Ê: EndoTODAY À§¾Ï 552¸¦ º¸½Ê½Ã¿À.


[2025-5-26. YouTube °­ÀÇ] EGC-like AGC

2025-5-26


[2025-5-25. Á¤À±¼÷ ¼±»ý´Ô °­ÀÇ]

United European Gastroenterol J 2023

United European Gastroenterol J 2023


[2025-5-23] ³»½Ã°æ Áõ·Ê¸¦ ÅëÇØ È®ÀÎÇÏ´Â ¼Ó ½Ã¿ø~ÇÑ Q and A. ÀÌÁØÇà, À̼±¿µ, ±èż¼

Dr. Ville log-in é©

© ÀÏ¿ø³»½Ã°æ±³½Ç ¹Ù¸¥³»½Ã°æ¿¬±¸¼Ò ÀÌÁØÇà. EndoTODAY Endoscopy Learning Center. Lee Jun Haeng.